A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation
2 other identifiers
interventional
40
0 countries
N/A
Brief Summary
This phase II trial studies how well deep inspiratory breath hold or prone breast radiation therapy works in reducing cardiac dose in patients with breast cancer or ductal carcinoma in situ. Deep inspiratory breath hold is a technique that involves a patient holding their breath during radiation to move the heart away from the breast to minimize radiation to the heart. Prone breast radiation therapy is a technique in which a patient receives treatment "face-down" to minimize the radiation to the rest of the body, including the heart and lungs. Comparing deep inspiratory breath hold to prone breast radiation therapy may help doctors improve radiation to the target while reducing radiation to healthy tissues surrounding the target.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Jan 2017
Longer than P75 for not_applicable breast-cancer
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2017
CompletedFirst Submitted
Initial submission to the registry
February 5, 2018
CompletedFirst Posted
Study publicly available on registry
February 19, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2023
CompletedFebruary 17, 2023
February 1, 2023
8 months
February 5, 2018
February 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean cardiac dose
Assess whether the mean cardiac dose in the supine DIBH plan differs from the mean cardiac dose in the prone plan within strata defined by total RT dose.
Up to 6 weeks
Secondary Outcomes (12)
Volume of heart receiving > 20 gray (Gy)
Up to 6 weeks
Mean left anterior descending artery (LAD) dose in DIBH plan vs. prone plan
Up to 6 weeks
Maximum left anterior descending artery (LAD) dose in DIBH plan vs. prone plan
Up to 6 weeks
Mean ipsilateral lung dose
Up to 6 weeks
Volume of ipsilateral lung receiving > 20Gy
Up to 6 weeks
- +7 more secondary outcomes
Study Arms (1)
Radiation Therapy (RT)
EXPERIMENTALPatients attend a simulation visit and undergo two CT scans, one in the prone position and one in the supine position with DIBH. Within 1 week after the simulation visit, patients undergo radiation therapy either in the supine position with DIBH or in the prone position daily for 15-30 consecutive days as per physician's prescription.
Interventions
Undergo RT either in the supine position with DIBH or in the prone position.
Eligibility Criteria
You may qualify if:
- Any woman with biopsy proven left breast DCIS or invasive cancer who has undergone a lumpectomy and who requires whole breast irradiation to the breast alone (and not to any nodal regions) as per the treating radiation oncologist
You may not qualify if:
- Previous radiation to the ipsilateral breast
- All pre-menopausal women will require a urine qualitative pregnancy test to exclude pregnancy; pregnant women will be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naamit Gerber, MD
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2018
First Posted
February 19, 2018
Study Start
January 17, 2017
Primary Completion
September 26, 2017
Study Completion
February 15, 2023
Last Updated
February 17, 2023
Record last verified: 2023-02